We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.29B
AUM Growth
+$344M
Cap. Flow
+$361M
Cap. Flow %
27.99%
Top 10 Hldgs %
48.42%
Holding
224
New
136
Increased
40
Reduced
37
Closed
9

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$25.8M
2
AFL icon
Aflac
AFL
+$20.3M
3
IBM icon
IBM
IBM
+$17.7M
4
AAPL icon
Apple
AAPL
+$14M
5
META icon
Meta Platforms (Facebook)
META
+$13.5M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$13.8M
2
PG icon
Procter & Gamble
PG
+$8M
3
T
A T & T CORP (NEW)
T
+$5.82M
4
CL icon
Colgate-Palmolive
CL
+$4.63M
5
MDT icon
Medtronic
MDT
+$3.09M

Sector Composition

Rank Sector Weight
1 Consumer Staples 32.66%
2 Healthcare 16.05%
3 Financials 9.3%
4 Technology 9.12%
5 Energy 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
101
Costco
COST
$432B
$2.59M 0.2%
+17,090
New +$2.51M
HD icon
102
Home Depot
HD
$337B
$2.56M 0.2%
22,540
-15,300
-40% -$1.69M
AET
103
DELISTED
Aetna Inc
AET
$2.5M 0.19%
+23,477
New +$2.3M
GILD icon
104
Gilead Sciences
GILD
$165B
$2.49M 0.19%
+25,370
New +$2.58M
GM
105
DELISTED
GEN MOTORS CORP
GM
$2.42M 0.19%
+64,650
New +$2.42M
PX
106
DELISTED
Praxair Inc
PX
$2.38M 0.18%
19,740
+2,960
+18% +$370K
MPC icon
107
Marathon Petroleum
MPC
$90.1B
$2.37M 0.18%
+46,290
New +$2.22M
LLY icon
108
Eli Lilly
LLY
$1.08T
$2.26M 0.18%
31,100
-200
-0.6% -$14.2K
EXC icon
109
Exelon
EXC
$48.1B
$2.21M 0.17%
+92,217
New +$2.28M
ORCL icon
110
Oracle
ORCL
$339B
$2.08M 0.16%
48,130
+1,800
+4% +$78K
MO icon
111
Altria Group
MO
$125B
$2.06M 0.16%
41,201
+546
+1% +$29K
PM icon
112
Philip Morris
PM
$309B
$2.03M 0.16%
+26,916
New +$2.18M
SWK icon
113
Stanley Black & Decker
SWK
$14.5B
$1.99M 0.15%
+20,912
New +$2M
BP icon
114
BP
BP
$112B
$1.96M 0.15%
60,393
-7,171
-11% -$235K
CCI icon
115
Crown Castle
CCI
$34.6B
$1.92M 0.15%
+23,250
New +$1.98M
DEO icon
116
Diageo
DEO
$49.6B
$1.9M 0.15%
17,200
-1,406
-8% -$162K
CI icon
117
Cigna
CI
$78.4B
$1.9M 0.15%
14,643
-97
-0.7% -$11.3K
HOT
118
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$1.89M 0.15%
+22,600
New +$1.77M
STJ
119
DELISTED
St Jude Medical
STJ
$1.83M 0.14%
28,000
+5,900
+27% +$392K
CA
120
DELISTED
CA, Inc.
CA
$1.75M 0.14%
+53,700
New +$1.7M
GAP
121
The Gap Inc
GAP
$7.3B
$1.71M 0.13%
39,450
+2,945
+8% +$123K
DVN icon
122
Devon Energy
DVN
$51.3B
$1.68M 0.13%
27,860
+2,400
+9% +$146K
MRO
123
DELISTED
Marathon Oil Corporation
MRO
$1.68M 0.13%
+64,250
New +$1.74M
AAP icon
124
Advance Auto Parts
AAP
$3.53B
$1.66M 0.13%
+11,100
New +$1.71M
CSX icon
125
CSX Corp
CSX
$94B
$1.63M 0.13%
147,372
+6,795
+5% +$78.1K

Similar funds

Cullinan Associates's Q1 2015 Portfolio in Review

As of Q1 2015, Cullinan Associates held 224 positions worth $1.29B, up 36% from $945M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Cullinan Associates deployed $361M of net new capital in Q1 2015, opening 136 new positions and adding to 40 existing holdings. Its largest new stake was Chevron: 241,639 shares worth $25.4M.

By sector, the portfolio is most concentrated in Consumer Staples at 33% of assets, down from 47% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $13.8M trimmed.

  • Cullinan Associates's largest Q1 2015 buy was Chevron: 241,639 shares worth $25.4M.
  • Cullinan Associates added most to Kellanova in Q1 2015, an estimated $2.63M increase.
  • Cullinan Associates's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $13.8M.
  • Cullinan Associates fully exited A T & T CORP (NEW) in Q1 2015, selling an estimated $5.82M.
  • Cullinan Associates's ten largest holdings make up 48% of its $1.29B portfolio in Q1 2015.
  • Cullinan Associates opened 136 new positions and closed 9 in Q1 2015.
  • Cullinan Associates's portfolio value rose 36% quarter-over-quarter to $1.29B.

Based on Cullinan Associates's 13F filing for Q1 2015, filed 14 Apr 2015.